Knowledge Ecology International
Attending and mending the knowledge ecosystem
Menu Close
  • About
  • Areas of work
  • Coronavirus
  • Xtandi
  • Listserves
  • Videos
  • Publications
  • Databases
  • Donate
Home»Blogs»Colombia issues a compulsory license on patents for the HIV drug Dolutegravir

Colombia issues a compulsory license on patents for the HIV drug Dolutegravir

Posted on April 24, 2024 by James Love

This is the 44 page decision:

NC_534_Licencia_obligatoria_aceptada

Arianna Schouten has a summary of the decision in English here:

23Apr2024-DecisionColombiaCLdolutegravir

Access to Medicine Colombia, compulsory license

Post navigation

Transparency mandate embedded into the proposed amendments to the International Health Regulations: Rationales underpinning the proposed Bureau’s text
April 22, 2024 WHO Pandemic agreement negotiating text

Categories

  • About
  • Access to Knowledge
  • Access to Medicine
  • AI
  • Competition
  • Delinkage
  • Economics
  • Events
  • Evidence
  • Government Funded research
  • influence
  • Intellectual Property Rights
  • Legislation
  • Litigation
  • Lobbying
  • Marketing
  • Meetings
  • Negotiations
  • Nuclear Proliferation
  • Orphan Drugs
  • Presentations
  • Privacy
  • Public Goods
  • Research and Development
  • Site Articles
  • Timelines
  • Trade
  • Transparency
  • WHO
  • WIPO
  • WTO
© 2024 Knowledge Ecology International. All rights reserved.
Hiero by aThemes